
    
      The phase III, efficacy trial of inactivated vaccine (vero cell) against EV71 has completed
      on March 2013 in China,and a follow up study for phase III clinical trial has completed on
      March 2014.

      On the basis of phase III, this study is the Phase IV, open-labelled research, in order to
      evaluate the 5-year immune persistence of EV71 vaccine.
    
  